medigraphic.com
ISSN 2594-1526 (Electronic)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2020, Number 3

<< Back Next >>

Neumol Cir Torax 2020; 79 (3)

Understanding of electronic nicotine delivery systems in resident physicians in a reference center of pulmonary diseases

Sánchez-Ríos CP, Rodríguez-Cid JR, Martínez-Barrera LM, Santillán-Doherty P, Alatorre-Alexander JA

Language: Spanish
References: 16
Page: 164-170
PDF size: 252.89 Kb.


ABSTRACT

Introduction: Smoking remains a public health problem. It is considered the leading cause of preventable death in the world. In our country, despite anti-tobacco policies, the lack of regulation of trade in ENDS (Electronic Nicotine Delivery Systems) and its use in the population of young schoolchildren due to lack of information about short-term health risks remains a problem and medium term and that, increase the risk of continuing to smoke in smokers who use it as a smoking cessation therapy and of falling into conventional tobacco use in non-smokers. Objective: To describe the knowledge of the resident physicians of pulmonology about the END. Material and methods: Prospective cross-sectional observational study on the knowledge of END in pulmonary residents, a survey with 15 multiple-choice items was applied. The results were evaluated and expressed using measures of central tendency. Results: It was found that 60% of the doctors had knowledge of END, only 66.67% had knowledge about the functioning. 90% do not recommend it due to lack of effectiveness and 90% said they ignore legal issues. 50% do not know information about security, 86.67% do not know about cost information. 90% considered needing more information about the END. Conclusions: The clear need to improve the knowledge of END in medical pulmonologists in training is demonstrated.


REFERENCES

  1. Chand HS, Muthumalage T, Maziak W, Rahman I. Pulmonary toxicity and the pathophysiology of electronic cigarette, or vaping product, use associated lung injury. Front Pharmacol. 2020;10:1619. https://doi.org/10.3389/fphar.2019.01619

  2. Dinakar C, O’Connor GT. The health effects of electronic cigarettes. N Engl J Med. 2016;375(14):1372-1381. https://doi.org/10.1056/nejmra1502466

  3. Leduc C, Quoix E. Is there a role for e-cigarettes in smoking cessation? Ther Adv Respir Dis. 2016;10(2):130-135. https://doi.org/10.1177/1753465815621233

  4. Yoong SL, Stockings E, Chai LK, Tzelepis F, Wiggers J, Oldmeadow C, et al. Prevalence of electronic nicotine delivery systems (ENDS) use among youth globally: a systematic review and meta-analysis of country level data. Aust NZ J Public Health. 2018;42(3):303-308. https://doi.org/10.1111/1753-6405.12777

  5. Orellana-Barrios MA, Payne D, Mulkey Z, Nugent K. Electronic cigarettes-a narrative review for clinicians. Am J Med. 2015;128(7):674-681. https://doi.org/10.1016/j.amjmed.2015.01.033

  6. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018;5(5):CD000146. https://doi.org/10.1002/14651858.cd000146.pub5

  7. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev. 2014;(12):CD010216. https://doi.org/10.1002/14651858.cd010216.pub2

  8. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Smith KM, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629-637. https://doi.org/10.1056/nejmoa1808779

  9. Livingstone-Banks J, Norris E, Hartmann-Boyce J, West R, Jarvis M, Hajek P. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. 2019;2(2):CD003999. https://doi.org/10.1002/14651858.cd003999.pub5

  10. Moyo F, Archibald E, Slyer JT. Effectiveness of decision aids for smoking cessation in adults: a quantitative systematic review. JBI Database System Rev Implement Rep. 2018;16(9):1791-1822. https://doi.org/10.11124/jbisrir-2017-003698

  11. Cigarrillo electrónico y demás ENDS. Fecha de consulta: 10 de enero, 2020. Accesible en: https://smnyct.org/informacion-general/cigarrillo-electronico-y-demas-ends-documento-de-posicion-aamr-alat-ers-separ-serchile-smnyct#attachmentsHeader

  12. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014;129(19):1972-1986. https://doi.org/10.1161/circulationaha.114.007667

  13. Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman S, Riggs NR, et al. Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015;314(7):700-707. https://doi.org/10.1001/jama.2015.8950

  14. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Smith KM, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629-637. https://doi.org/10.1056/nejmoa1808779

  15. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, Mclntosh S, et al. Vapors produced by electronic cigarettes and e-juices with flavoring induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One. 2015;10(2): e0116732. https://doi.org/10.1371/journal.pone.0116732

  16. Varlet V, Farsalinos K, Augsburger M, Thomas A, Etter JF. Toxicity assessment of refill liquids for electronic cigarettes. Int J Environ Res Public. Health 2015;12(5):4796-4815. https://doi.org/10.3390/ijerph120504796




2020     |     www.medigraphic.com